Drug Delivery Devices - North America

North America

Highlights

In North America, revenue in the Drug Delivery Devices market market is projected to reach US$16.14bn in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 4.67%, leading to a market volume of US$20.27bn by 2029.
In a global context, the majority of revenue will be generated the United States, amounting to US$15.01bn in 2024.
In North America, the increasing prevalence of chronic diseases is driving innovation and demand for advanced drug delivery devices in the medical technology sector.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market in North America is experiencing mild growth, influenced by factors such as technological advancements, increasing chronic disease prevalence, and the demand for patient-centric solutions. Regulatory challenges also impact the pace of this growth.

Customer preferences: Consumers are increasingly favoring personalized and user-friendly drug delivery devices that cater to their specific health needs, which is driving innovation in the market. The rise of telehealth services has heightened the demand for devices that integrate seamlessly with digital platforms for medication management. Additionally, an aging population and a growing focus on preventative care are pushing for more sophisticated solutions that provide convenience and enhance adherence to treatment protocols. This trend reflects a cultural shift towards proactive health management.

Trends in the market: In North America, the Drug Delivery Devices Market is experiencing a surge in demand for smart, connected devices that enhance patient engagement and adherence to therapies. As patients increasingly prioritize personalized healthcare solutions, manufacturers are innovating to create user-friendly devices that integrate with mobile health applications. The emphasis on preventative care, particularly among the aging population, is driving the development of advanced delivery systems that offer precise dosing and real-time feedback. This evolution presents significant opportunities for industry stakeholders to invest in R&D, collaborate with tech companies, and improve patient outcomes through enhanced medication management.

Local special circumstances: In North America, the Drug Delivery Devices Market is shaped by a strong emphasis on regulatory compliance and patient safety, influenced by stringent FDA guidelines. The diverse cultural landscape also plays a role, as varying health literacy levels impact patient engagement and device adoption. Additionally, the widespread use of health insurance programs facilitates access to innovative devices, fostering a competitive environment for manufacturers. This combination of regulatory rigor and cultural diversity drives advancements in personalized drug delivery solutions that cater to a tech-savvy consumer base.

Underlying macroeconomic factors: The Drug Delivery Devices Market in North America is significantly influenced by overarching macroeconomic factors such as technological innovation, healthcare expenditure, and regulatory frameworks. Economic stability and growth in the region have led to increased investments in R&D, enhancing the development of advanced drug delivery solutions. Additionally, favorable fiscal policies that support healthcare initiatives contribute to greater accessibility and adoption of these devices. The rising prevalence of chronic diseases and an aging population further propel demand, as patients seek effective and personalized treatment options. Collectively, these factors create a dynamic environment that fosters market growth and innovation in drug delivery technologies.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.